Download PDF
Hamostaseologie 2019; 39(02): 128-139
DOI: 10.1055/s-0038-1675614
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Role of Endothelial Cells in Acute and Chronic Thrombosis

Magdalena L. Bochenek
1   Center for Thrombosis and Hemostasis, University Medical Center Mainz, Mainz, Germany
2   Center for Cardiology, Cardiology I, University Medical Center Mainz, Mainz, Germany
3   Deutsches Zentrum für Herz-Kreislauf-Forschung e.V., Partner Site Rhein Main, Mainz, Germany
4   Center for Translational Vascular Biology, University Medical Center Mainz, Mainz, Germany
,
Katrin Schäfer
2   Center for Cardiology, Cardiology I, University Medical Center Mainz, Mainz, Germany
3   Deutsches Zentrum für Herz-Kreislauf-Forschung e.V., Partner Site Rhein Main, Mainz, Germany
4   Center for Translational Vascular Biology, University Medical Center Mainz, Mainz, Germany
› Author Affiliations
Further Information

Publication History

21 June 2018

28 September 2018

Publication Date:
08 January 2019 (online)

Also available at
   Permissions and Reprints

Abstract

Haemostasis encompasses a set of strictly regulated actions, such as vasoconstriction, platelet activation and blood coagulation. Endothelial cells play a crucial role in all of these processes and are an integral part of the vascular response to injury resulting in thrombus formation. Healthy endothelium expresses mediators to prevent platelet activation, including prostacyclin and nitric oxide, and to inhibit coagulation, such as thrombomodulin or RNase1. Upon activation, endothelial cells expose von Willebrand factor, integrins and other receptors to interact with activated platelets, erythrocytes and coagulation factors, respectively, resulting in blood clot formation. The endothelial cell response to cytokines and growth factors released from activated platelets and immune cells abundantly present in arterial and venous thrombi also plays an important role for thrombus resolution, whereas failure to completely resolve thrombi may initiate fibrotic remodelling and chronic vascular occlusion both in the arterial and venous tree. Therefore, endothelial cells are increasingly recognized as potential target to prevent thrombotic events and to accelerate thrombus resolution. Here, we discuss recent publications from our group in the context of other studies on the role of the endothelium during acute and chronic thrombotic events.

Zusammenfassung

Die Hämostase umfasst eine Reihe von streng regulierten Abläufen wie Vasokonstriktion, Thrombozytenaktivierung und Blutgerinnung. Endothelzellen spielen eine entscheidende Rolle in all diesen Prozessen und sind ein integraler Bestandteil der vaskulären Antwort auf Verletzungen, die zur Thrombusbildung führen. Gesundes Endothel exprimiert Mediatoren zur Verhinderung der Thrombozytenaktivierung einschließlich Prostacyclin und Stickoxid und zur Hemmung der Gerinnung, wie Thrombomodulin oder RNase1. Nach der Aktivierung exponieren Endothelzellen den von Willebrand-Faktor, Integrine und andere Rezeptoren, um mit aktivierten Thrombozyten, Erythrozyten bzw. Gerinnungsfaktoren zu interagieren, was zur Bildung von Blutgerinnseln führt. Die Endothelzellenantwort auf Cytokine und Wachstumsfaktoren, die von aktivierten Blutplättchen und Immunzellen in arteriellen und venösen Thromben freigesetzt werden, spielt ebenfalls eine wichtige Rolle bei der Thrombusauflösung, während eine unvollständige Auflösung von Thromben fibrotische Umbauprozesse und einen chronischen Gefäßverschluss sowohl im arteriellen als auch im venösen Bereich auslösen kann. Daher werden Endothelzellen zunehmend als potenzielles Ziel zur Vorbeugung thrombotischer Ereignisse und zur Beschleunigung der Thrombusauflösung erkannt. Hier diskutieren wir aktuelle Publikationen aus unserer Gruppe im Zusammenhang mit anderen Studien zur Rolle des Endothels bei akuten und chronischen thrombotischen Ereignissen.

Keywords

arterial - endothelial dysfunction - thrombosis - thrombus resolution - venous

Schlüsselwörter

arteriell - endotheliale Dysfunktion - Thrombose - Thrombusauflösung - venös

Authors' Contribution

M.L.B. and K.S. wrote the manuscript and acquired funding. Both authors have read and approved the final manuscript.


 

  • References

  • 1 Colburn P, Buonassisi V. Anti-clotting activity of endothelial cell cultures and heparan sulfate proteoglycans. Biochem Biophys Res Commun 1982; 104 (01) 220-227
    CrossrefPubMedGoogle Scholar
  • 2 Marcus AJ, Broekman MJ, Drosopoulos JH. , et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 1997; 99 (06) 1351-1360
    CrossrefPubMedGoogle Scholar
  • 3 Moncada S, Gryglewski R, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976; 263 (5579): 663-665
    CrossrefPubMedGoogle Scholar
  • 4 Mellion BT, Ignarro LJ, Ohlstein EH, Pontecorvo EG, Hyman AL, Kadowitz PJ. Evidence for the inhibitory role of guanosine 3′, 5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 1981; 57 (05) 946-955
    CrossrefPubMedGoogle Scholar
  • 5 Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; 2 (8567): 1057-1058
    PubMedGoogle Scholar
  • 6 Yau JW, Teoh H, Verma S. Endothelial cell control of thrombosis. BMC Cardiovasc Disord 2015; 15: 130
    CrossrefPubMedGoogle Scholar
  • 7 Landré JB, Hewett PW, Olivot JM. , et al. Human endothelial cells selectively express large amounts of pancreatic-type ribonuclease (RNase 1). J Cell Biochem 2002; 86 (03) 540-552
    CrossrefPubMedGoogle Scholar
  • 8 Gansler J, Preissner KT, Fischer S. Influence of proinflammatory stimuli on the expression of vascular ribonuclease 1 in endothelial cells. FASEB J 2014; 28 (02) 752-760
    CrossrefPubMedGoogle Scholar
  • 9 Lollar P, Owen WG. Clearance of thrombin from circulation in rabbits by high-affinity binding sites on endothelium. Possible role in the inactivation of thrombin by antithrombin III. J Clin Invest 1980; 66 (06) 1222-1230
    CrossrefPubMedGoogle Scholar
  • 10 Kannemeier C, Shibamiya A, Nakazawa F. , et al. Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci U S A 2007; 104 (15) 6388-6393
    CrossrefPubMedGoogle Scholar
  • 11 Nieuwdorp M, van Haeften TW, Gouverneur MC. , et al. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 2006; 55 (02) 480-486
    CrossrefPubMedGoogle Scholar
  • 12 Van de Wouwer M, Collen D, Conway EM. Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation. Arterioscler Thromb Vasc Biol 2004; 24 (08) 1374-1383
    CrossrefPubMedGoogle Scholar
  • 13 Loghmani H, Conway EM. Exploring traditional and nontraditional roles for thrombomodulin. Blood 2018; 132 (02) 148-158
    PubMedGoogle Scholar
  • 14 Moore KL, Esmon CT, Esmon NL. Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood 1989; 73 (01) 159-165
    CrossrefPubMedGoogle Scholar
  • 15 Frydland M, Ostrowski SR, Møller JE. , et al. Plasma concentration of biomarkers reflecting endothelial cell- and glycocalyx damage are increased in patients with suspected ST-Elevation myocardial infarction complicated by cardiogenic shock. Shock 2018; 50 (05) 538-544
    CrossrefPubMedGoogle Scholar
  • 16 Warn-Cramer BJ, Almus FE, Rapaport SI. Studies of the factor Xa-dependent inhibitor of factor VIIa/tissue factor (extrinsic pathway inhibitor) from cell supernates of cultured human umbilical vein endothelial cells. Thromb Haemost 1989; 61 (01) 101-105
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 White TA, Johnson T, Zarzhevsky N. , et al. Endothelial-derived tissue factor pathway inhibitor regulates arterial thrombosis but is not required for development or hemostasis. Blood 2010; 116 (10) 1787-1794
    PubMedGoogle Scholar
  • 18 Figueras J, Monasterio J, Lidón RM, Sambola A, Garcia-Dorado D. Lower tissue factor inhibition in patients with ST segment elevation than in patients with non ST elevation acute myocardial infarction. Thromb Res 2012; 130 (03) 458-462
    CrossrefPubMedGoogle Scholar
  • 19 Rossouw JE, Johnson KC, Pettinger M. , et al. Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due to postmenopausal hormone therapy. Stroke 2012; 43 (04) 952-957
    CrossrefPubMedGoogle Scholar
  • 20 Dahm A, Van Hylckama Vlieg A, Bendz B, Rosendaal F, Bertina RM, Sandset PM. Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis. Blood 2003; 101 (11) 4387-4392
    CrossrefPubMedGoogle Scholar
  • 21 Aird WC. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res 2007; 100 (02) 174-190
    CrossrefPubMedGoogle Scholar
  • 22 Aird WC. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 2007; 100 (02) 158-173
    CrossrefPubMedGoogle Scholar
  • 23 Ishii H, Salem HH, Bell CE, Laposata EA, Majerus PW. Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain. Blood 1986; 67 (02) 362-365
    CrossrefPubMedGoogle Scholar
  • 24 Laszik Z, Mitro A, Taylor Jr FB, Ferrell G, Esmon CT. Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway. Circulation 1997; 96 (10) 3633-3640
    CrossrefPubMedGoogle Scholar
  • 25 Tandon NN, Kralisz U, Jamieson GA. Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem 1989; 264 (13) 7576-7583
    CrossrefPubMedGoogle Scholar
  • 26 Chi JT, Chang HY, Haraldsen G. , et al. Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci U S A 2003; 100 (19) 10623-10628
    CrossrefPubMedGoogle Scholar
  • 27 Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 2000; 407 (6801): 258-264
    CrossrefPubMedGoogle Scholar
  • 28 O'Brien PJ, Prevost N, Molino M. , et al. Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1. J Biol Chem 2000; 275 (18) 13502-13509
    CrossrefPubMedGoogle Scholar
  • 29 Camerer E, Huang W, Coughlin SR. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A 2000; 97 (10) 5255-5260
    CrossrefPubMedGoogle Scholar
  • 30 Molino M, Woolkalis MJ, Reavey-Cantwell J. , et al. Endothelial cell thrombin receptors and PAR-2. Two protease-activated receptors located in a single cellular environment. J Biol Chem 1997; 272 (17) 11133-11141
    CrossrefPubMedGoogle Scholar
  • 31 Storck J, Küsters B, Zimmermann ER. The tethered ligand receptor is the responsible receptor for the thrombin induced release of von Willebrand factor from endothelial cells (HUVEC). Thromb Res 1995; 77 (03) 249-258
    CrossrefPubMedGoogle Scholar
  • 32 Alm AK, Norström E, Sundelin J, Nystedt S. Stimulation of proteinase activated receptor-2 causes endothelial cells to promote blood coagulation in vitro. Thromb Haemost 1999; 81 (06) 984-988
    Article in Thieme ConnectPubMedGoogle Scholar
  • 33 Bouwens EA, Stavenuiter F, Mosnier LO. Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway. J Thromb Haemost 2013; 11 (Suppl. 01) 242-253
    CrossrefPubMedGoogle Scholar
  • 34 De Ceunynck K, Peters CG, Jain A. , et al. PAR1 agonists stimulate APC-like endothelial cytoprotection and confer resistance to thromboinflammatory injury. Proc Natl Acad Sci U S A 2018; 115 (05) E982-E991
    CrossrefPubMedGoogle Scholar
  • 35 Brill A, Elinav H, Varon D. Differential role of platelet granular mediators in angiogenesis. Cardiovasc Res 2004; 63 (02) 226-235
    CrossrefPubMedGoogle Scholar
  • 36 Arisato T, Hashiguchi T, Sarker KP. , et al. Highly accumulated platelet vascular endothelial growth factor in coagulant thrombotic region. J Thromb Haemost 2003; 1 (12) 2589-2593
    CrossrefPubMedGoogle Scholar
  • 37 Waltham M, Burnand KG, Collins M, McGuinness CL, Singh I, Smith A. Vascular endothelial growth factor enhances venous thrombus recanalisation and organisation. Thromb Haemost 2003; 89 (01) 169-176
    Article in Thieme ConnectPubMedGoogle Scholar
  • 38 Evans CE, Grover SP, Humphries J. , et al. Antiangiogenic therapy inhibits venous thrombus resolution. Arterioscler Thromb Vasc Biol 2014; 34 (03) 565-570
    CrossrefPubMedGoogle Scholar
  • 39 Alias S, Redwan B, Panzenboeck A. , et al. Defective angiogenesis delays thrombus resolution: a potential pathogenetic mechanism underlying chronic thromboembolic pulmonary hypertension. Arterioscler Thromb Vasc Biol 2014; 34 (04) 810-819
    CrossrefPubMedGoogle Scholar
  • 40 Campbell JH, Campbell GR. Endothelial cell influences on vascular smooth muscle phenotype. Annu Rev Physiol 1986; 48: 295-306
    CrossrefPubMedGoogle Scholar
  • 41 Modarai B, Burnand KG, Humphries J, Waltham M, Smith A. The role of neovascularisation in the resolution of venous thrombus. Thromb Haemost 2005; 93 (05) 801-809
    Article in Thieme ConnectPubMedGoogle Scholar
  • 42 Griese DP, Ehsan A, Melo LG. , et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 2003; 108 (21) 2710-2715
    CrossrefPubMedGoogle Scholar
  • 43 Schroeter MR, Leifheit M, Sudholt P. , et al. Leptin enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting integrin-mediated adhesion. Circ Res 2008; 103 (05) 536-544
    CrossrefPubMedGoogle Scholar
  • 44 Li WD, Li XQ. Endothelial progenitor cells accelerate the resolution of deep vein thrombosis. Vascul Pharmacol 2016; 83: 10-16
    CrossrefPubMedGoogle Scholar
  • 45 Schütz E, Bochenek ML, Riehl DR. , et al. Absence of transforming growth factor beta 1 in murine platelets reduces neointima formation without affecting arterial thrombosis. Thromb Haemost 2017; 117 (09) 1782-1797
    Article in Thieme ConnectPubMedGoogle Scholar
  • 46 Heimark RL, Twardzik DR, Schwartz SM. Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science 1986; 233 (4768): 1078-1080
    CrossrefPubMedGoogle Scholar
  • 47 Cooley BC, Nevado J, Mellad J. , et al. TGF-β signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling. Sci Transl Med 2014; 6 (227) 227ra34
    CrossrefPubMedGoogle Scholar
  • 48 Jäger M, Hubert A, Gogiraju R, Bochenek ML, Münzel T, Schäfer K. Inducible knockdown of endothelial protein tyrosine phosphatase-1B promotes neointima formation in obese mice by enhancing endothelial senescence. Antioxid Redox Signal 2018 ;•••: [Epub ahead of print];. Doi: 10.1089/ars.2017.7169
    PubMedGoogle Scholar
  • 49 Kellermair J, Redwan B, Alias S. , et al. Platelet endothelial cell adhesion molecule 1 deficiency misguides venous thrombus resolution. Blood 2013; 122 (19) 3376-3384
    PubMedGoogle Scholar
  • 50 Kohno M, Yasunari K, Yokokawa K. , et al. Thrombin stimulates the production of immunoreactive endothelin-1 in cultured human umbilical vein endothelial cells. Metabolism 1990; 39 (10) 1003-1005
    CrossrefPubMedGoogle Scholar
  • 51 Ruggeri ZM, Mendolicchio GL. Interaction of von Willebrand factor with platelets and the vessel wall. Hamostaseologie 2015; 35 (03) 211-224
    Article in Thieme ConnectPubMedGoogle Scholar
  • 52 Brill A, Fuchs TA, Chauhan AK. , et al. von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood 2011; 117 (04) 1400-1407
    CrossrefPubMedGoogle Scholar
  • 53 Turner N, Nolasco L, Tao Z, Dong JF, Moake J. Human endothelial cells synthesize and release ADAMTS-13. J Thromb Haemost 2006; 4 (06) 1396-1404
    CrossrefPubMedGoogle Scholar
  • 54 Vomund AN, Majerus EM. ADAMTS13 bound to endothelial cells exhibits enhanced cleavage of von Willebrand factor. J Biol Chem 2009; 284 (45) 30925-30932
    CrossrefPubMedGoogle Scholar
  • 55 Levy GG, Nichols WC, Lian EC. , et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001; 413 (6855): 488-494
    CrossrefPubMedGoogle Scholar
  • 56 Lämmle B, Kremer Hovinga JA, George JN. Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease. Haematologica 2008; 93 (02) 172-177
    CrossrefPubMedGoogle Scholar
  • 57 Kaikita K, Soejima K, Matsukawa M, Nakagaki T, Ogawa H. Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction. J Thromb Haemost 2006; 4 (11) 2490-2493
    CrossrefPubMedGoogle Scholar
  • 58 Bongers TN, de Maat MP, van Goor ML. , et al. High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability. Stroke 2006; 37 (11) 2672-2677
    CrossrefPubMedGoogle Scholar
  • 59 Li Z, Nardi MA, Li YS. , et al. C-terminal ADAMTS-18 fragment induces oxidative platelet fragmentation, dissolves platelet aggregates, and protects against carotid artery occlusion and cerebral stroke. Blood 2009; 113 (24) 6051-6060
    CrossrefPubMedGoogle Scholar
  • 60 Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone Jr MA. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 1984; 160 (02) 618-623
    CrossrefPubMedGoogle Scholar
  • 61 Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 2004; 24 (06) 1015-1022
    CrossrefPubMedGoogle Scholar
  • 62 Lawson CA, Yan SD, Yan SF. , et al. Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation. J Clin Invest 1997; 99 (07) 1729-1738
    CrossrefPubMedGoogle Scholar
  • 63 Uchiyama T, Kurabayashi M, Ohyama Y. , et al. Hypoxia induces transcription of the plasminogen activator inhibitor-1 gene through genistein-sensitive tyrosine kinase pathways in vascular endothelial cells. Arterioscler Thromb Vasc Biol 2000; 20 (04) 1155-1161
    CrossrefPubMedGoogle Scholar
  • 64 Mojiri A, Nakhaii-Nejad M, Phan WL. , et al. Hypoxia results in upregulation and de novo activation of von Willebrand factor expression in lung endothelial cells. Arterioscler Thromb Vasc Biol 2013; 33 (06) 1329-1338
    CrossrefPubMedGoogle Scholar
  • 65 Brill A, Suidan GL, Wagner DD. Hypoxia, such as encountered at high altitude, promotes deep vein thrombosis in mice. J Thromb Haemost 2013; 11 (09) 1773-1775
    CrossrefPubMedGoogle Scholar
  • 66 Myers Jr D, Farris D, Hawley A. , et al. Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis. J Surg Res 2002; 108 (02) 212-221
    CrossrefPubMedGoogle Scholar
  • 67 Iba T, Levy JH. Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis. J Thromb Haemost 2018; 16 (02) 231-241
    CrossrefPubMedGoogle Scholar
  • 68 von Brühl ML, Stark K, Steinhart A. , et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012; 209 (04) 819-835
    CrossrefPubMedGoogle Scholar
  • 69 Wakefield TW, Linn MJ, Henke PK. , et al. Neovascularization during venous thrombosis organization: a preliminary study. J Vasc Surg 1999; 30 (05) 885-892
    CrossrefPubMedGoogle Scholar
  • 70 Bochenek ML, Rosinus NS, Lankeit M. , et al. From thrombosis to fibrosis in chronic thromboembolic pulmonary hypertension. Thromb Haemost 2017; 117 (04) 769-783
    Article in Thieme ConnectPubMedGoogle Scholar
  • 71 Evans CE, Wadoodi A, Humphries J. , et al. Local accumulation of hypoxia-inducible factor 2 alpha during venous thrombus resolution. Thromb Res 2014; 134 (03) 757-760
    CrossrefPubMedGoogle Scholar
  • 72 Luther N, Shahneh F, Brähler M. , et al. Innate effector-memory T-cell activation regulates post-thrombotic vein wall inflammation and thrombus resolution. Circ Res 2016; 119 (12) 1286-1295
    CrossrefPubMedGoogle Scholar
  • 73 Nosaka M, Ishida Y, Kimura A. , et al. Absence of IFN-γ accelerates thrombus resolution through enhanced MMP-9 and VEGF expression in mice. J Clin Invest 2011; 121 (07) 2911-2920
    CrossrefPubMedGoogle Scholar
  • 74 Westrick RJ, Winn ME, Eitzman DT. Murine models of vascular thrombosis (Eitzman series). Arterioscler Thromb Vasc Biol 2007; 27 (10) 2079-2093
    CrossrefPubMedGoogle Scholar
  • 75 Mackman N. Mouse models, risk factors, and treatments of venous thrombosis. Arterioscler Thromb Vasc Biol 2012; 32 (03) 554-555
    CrossrefPubMedGoogle Scholar
  • 76 Kumar A, Kim CS, Hoffman TA. , et al. p53 impairs endothelial function by transcriptionally repressing Kruppel-like factor 2. Arterioscler Thromb Vasc Biol 2011; 31 (01) 133-141
    CrossrefPubMedGoogle Scholar
  • 77 Bochenek ML, Bauer T, Gogiraju R. , et al. The endothelial tumor suppressor p53 is essential for venous thrombus formation in aged mice. Blood Adv 2018; 2 (11) 1300-1314
    CrossrefPubMedGoogle Scholar
  • 78 McDonald AP, Meier TR, Hawley AE. , et al. Aging is associated with impaired thrombus resolution in a mouse model of stasis induced thrombosis. Thromb Res 2010; 125 (01) 72-78
    CrossrefPubMedGoogle Scholar
  • 79 Culmer DL, Diaz JA, Hawley AE. , et al. Circulating and vein wall P-selectin promote venous thrombogenesis during aging in a rodent model. Thromb Res 2013; 131 (01) 42-48
    CrossrefPubMedGoogle Scholar
  • 80 Bochenek ML, Schütz E, Schäfer K. Endothelial cell senescence and thrombosis: Ageing clots. Thromb Res 2016; 147: 36-45
    CrossrefPubMedGoogle Scholar
  • 81 Vlodavsky I, Blich M, Li JP, Sanderson RD, Ilan N. Involvement of heparanase in atherosclerosis and other vessel wall pathologies. Matrix Biol 2013; 32 (05) 241-251
    CrossrefPubMedGoogle Scholar
  • 82 Baker AB, Gibson WJ, Kolachalama VB. , et al. Heparanase regulates thrombosis in vascular injury and stent-induced flow disturbance. J Am Coll Cardiol 2012; 59 (17) 1551-1560
    CrossrefPubMedGoogle Scholar
  • 83 Axelman E, Henig I, Crispel Y. , et al. Novel peptides that inhibit heparanase activation of the coagulation system. Thromb Haemost 2014; 112 (03) 466-477
    Article in Thieme ConnectPubMedGoogle Scholar
  • 84 Crispel Y, Axelman E, Tatour M. , et al. Peptides inhibiting heparanase procoagulant activity significantly reduce tumour growth and vascularisation in a mouse model. Thromb Haemost 2016; 116 (04) 669-678
    Article in Thieme ConnectPubMedGoogle Scholar
  • 85 Sprecher CA, Kisiel W, Mathewes S, Foster DC. Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor. Proc Natl Acad Sci U S A 1994; 91 (08) 3353-3357
    CrossrefPubMedGoogle Scholar
  • 86 Huang PL, Huang Z, Mashimo H. , et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995; 377 (6546): 239-242
    CrossrefPubMedGoogle Scholar
  • 87 Inoue O, Hokamura K, Shirai T. , et al. Vascular smooth muscle cells stimulate platelets and facilitate thrombus formation through platelet CLEC-2: implications in atherothrombosis. PLoS One 2015; 10 (09) e0139357
    CrossrefPubMedGoogle Scholar
  • 88 Kaul DK, Finnegan E, Barabino GA. Sickle red cell-endothelium interactions. Microcirculation 2009; 16 (01) 97-111
    CrossrefPubMedGoogle Scholar
  • 89 Smith JD, Rowe JA, Higgins MK, Lavstsen T. Malaria's deadly grip: cytoadhesion of Plasmodium falciparum-infected erythrocytes. Cell Microbiol 2013; 15 (12) 1976-1983
    CrossrefPubMedGoogle Scholar
  • 90 Grossin N, Wautier MP, Wautier JL. Red blood cell adhesion in diabetes mellitus is mediated by advanced glycation end product receptor and is modulated by nitric oxide. Biorheology 2009; 46 (01) 63-72
    CrossrefPubMedGoogle Scholar
  • 91 Spring FA, Parsons SF, Ortlepp S. , et al. Intercellular adhesion molecule-4 binds alpha(4)beta(1) and alpha(V)-family integrins through novel integrin-binding mechanisms. Blood 2001; 98 (02) 458-466
    CrossrefPubMedGoogle Scholar
  • 92 Hermand P, Gane P, Huet M. , et al. Red cell ICAM-4 is a novel ligand for platelet-activated alpha IIbbeta 3 integrin. J Biol Chem 2003; 278 (07) 4892-4898
    CrossrefPubMedGoogle Scholar
  • 93 Bailly P, Tontti E, Hermand P, Cartron JP, Gahmberg CG. The red cell LW blood group protein is an intercellular adhesion molecule which binds to CD11/CD18 leukocyte integrins. Eur J Immunol 1995; 25 (12) 3316-3320
    CrossrefPubMedGoogle Scholar
  • 94 Hebbel RP, Boogaerts MA, Eaton JW, Steinberg MH. Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity. N Engl J Med 1980; 302 (18) 992-995
    CrossrefPubMedGoogle Scholar
  • 95 Smeets MW, Bierings R, Meems H. , et al. Platelet-independent adhesion of calcium-loaded erythrocytes to von Willebrand factor. PLoS One 2017; 12 (03) e0173077
    CrossrefPubMedGoogle Scholar
  • 96 Thomsen RW, Schoonen WM, Farkas DK, Riis A, Fryzek JP, Sørensen HT. Risk of venous thromboembolism in splenectomized patients compared with the general population and appendectomized patients: a 10-year nationwide cohort study. J Thromb Haemost 2010; 8 (06) 1413-1416
    CrossrefPubMedGoogle Scholar
  • 97 Bonderman D, Wilkens H, Wakounig S. , et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J 2009; 33 (02) 325-331
    PubMedGoogle Scholar
  • 98 Frey MK, Alias S, Winter MP. , et al. Splenectomy is modifying the vascular remodeling of thrombosis. J Am Heart Assoc 2014; 3 (01) e000772
    PubMedGoogle Scholar
  • 99 Schäfer K, Konstantinides S, Riedel C. , et al. Different mechanisms of increased luminal stenosis after arterial injury in mice deficient for urokinase- or tissue-type plasminogen activator. Circulation 2002; 106 (14) 1847-1852
    CrossrefPubMedGoogle Scholar
  • 100 Yamamoto K, Takeshita K, Shimokawa T. , et al. Plasminogen activator inhibitor-1 is a major stress-regulated gene: implications for stress-induced thrombosis in aged individuals. Proc Natl Acad Sci U S A 2002; 99 (02) 890-895
    CrossrefPubMedGoogle Scholar
  • 101 Pomero F, Di Minno MN, Fenoglio L, Gianni M, Ageno W, Dentali F. Is diabetes a hypercoagulable state? A critical appraisal. Acta Diabetol 2015; 52 (06) 1007-1016
    CrossrefPubMedGoogle Scholar
  • 102 White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107 (23) (Suppl. 01) I4-I8
    PubMedGoogle Scholar
  • 103 Evans CE, Humphries J, Waltham M. , et al. Upregulation of hypoxia-inducible factor 1 alpha in local vein wall is associated with enhanced venous thrombus resolution. Thromb Res 2011; 128 (04) 346-351
    CrossrefPubMedGoogle Scholar
  • 104 Evans CE, Humphries J, Mattock K. , et al. Hypoxia and upregulation of hypoxia-inducible factor 1alpha stimulate venous thrombus recanalization. Arterioscler Thromb Vasc Biol 2010; 30 (12) 2443-2451
    CrossrefPubMedGoogle Scholar
  • 105 Modarai B, Humphries J, Burnand KG. , et al. Adenovirus-mediated VEGF gene therapy enhances venous thrombus recanalization and resolution. Arterioscler Thromb Vasc Biol 2008; 28 (10) 1753-1759
    CrossrefPubMedGoogle Scholar
  • 106 Varma MR, Moaveni DM, Dewyer NA. , et al. Deep vein thrombosis resolution is not accelerated with increased neovascularization. J Vasc Surg 2004; 40 (03) 536-542
    CrossrefPubMedGoogle Scholar
  • 107 Lee M, Keener J, Xiao J, Long Zheng X, Rodgers GM. ADAMTS13 and its variants promote angiogenesis via upregulation of VEGF and VEGFR2. Cell Mol Life Sci 2015; 72 (02) 349-356
    CrossrefPubMedGoogle Scholar
  • 108 Arderiu G, Peña E, Badimon L. Angiogenic microvascular endothelial cells release microparticles rich in tissue factor that promotes postischemic collateral vessel formation. Arterioscler Thromb Vasc Biol 2015; 35 (02) 348-357
    CrossrefPubMedGoogle Scholar
  • 109 Shaikh FM, Callanan A, Kavanagh EG, Burke PE, Grace PA, McGloughlin TM. Fibrin: a natural biodegradable scaffold in vascular tissue engineering. Cells Tissues Organs 2008; 188 (04) 333-346
    CrossrefPubMedGoogle Scholar
  • 110 Ribes JA, Ni F, Wagner DD, Francis CW. Mediation of fibrin-induced release of von Willebrand factor from cultured endothelial cells by the fibrin beta chain. J Clin Invest 1989; 84 (02) 435-442
    CrossrefPubMedGoogle Scholar
  • 111 Scholz A, Plate KH, Reiss Y. Angiopoietin-2: a multifaceted cytokine that functions in both angiogenesis and inflammation. Ann N Y Acad Sci 2015; 1347: 45-51
    CrossrefPubMedGoogle Scholar
  • 112 Rathnakumar K, Savant S, Giri H. , et al. Angiopoietin-2 mediates thrombin-induced monocyte adhesion and endothelial permeability. J Thromb Haemost 2016; 14 (08) 1655-1667
    CrossrefPubMedGoogle Scholar
  • 113 Higgins SJ, De Ceunynck K, Kellum JA. , et al. Tie2 protects the vasculature against thrombus formation in systemic inflammation. J Clin Invest 2018; 128 (04) 1471-1484
    CrossrefPubMedGoogle Scholar
  • 114 Walsh TG, Metharom P, Berndt MC. The functional role of platelets in the regulation of angiogenesis. Platelets 2015; 26 (03) 199-211
    CrossrefPubMedGoogle Scholar
  • 115 Su JB. Vascular endothelial dysfunction and pharmacological treatment. World J Cardiol 2015; 7 (11) 719-741
    CrossrefPubMedGoogle Scholar